Skip to main content
. 2021 Nov 12;22:796. doi: 10.1186/s13063-021-05783-8

Table 3.

Participant timeline

Study period
Enrolment Allocationa Monitoring during treatment End of treatment Follow-up since randomization (months)
Study phase Admission to randomization Weekly Bi-weekly 3 6 12b
Enrolment
Eligibility screen
Informed consent
Cranial imaging − 3 to 0 days
Allocation
Intervention ●-------------------------------------------------------------●
Assessments
E-GOS
Clinical examination
Cranial imaging
Morisky scores (oral arm)
Blood tests
SF-36 + EQ-5D-5L + MoCA
Screening for immunodeficiency

E-GOS Extended Glasgow Outcome Scale score. Blood tests include c-reactive protein, complete blood count, creatinine, liver function tests

aAfter 14 days or longer since definitive neurosurgical treatment or IV antibiotic therapy for brain abscess

bCan be replaced by telephone consultation